Effect of Addition and Subtraction Therapy of Yiyiren Tang with External Application Therapy on Inflammatory Factors of Patients with Acute Gouty Arthritis and Damp-heat Obstruction Syndrome

Yi-feng LIU; Lei CAO; Hua YANG; Yang-yang ZHENG

doi:10.13422/j.cnki.syfjx.20200132

您当前的位置：

首页 >

文章列表页 >

Effect of Addition and Subtraction Therapy of Yiyiren Tang with External Application Therapy on Inflammatory Factors of Patients with Acute Gouty Arthritis and Damp-heat Obstruction Syndrome

Clinic | 更新时间：2021-02-09

- Effect of Addition and Subtraction Therapy of Yiyiren Tang with External Application Therapy on Inflammatory Factors of Patients with Acute Gouty Arthritis and Damp-heat Obstruction Syndrome
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 9, Pages: 75-80(2020)
- 作者机构：
  
  海南省中医院，海口　 570203
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20200132
  CLC： R25; R256; R256.2; R289
- Received：03 September 2019，
  
  Published Online：21 October 2019，
  
  Published：05 May 2020
- 稿件说明：
移动端阅览
Yi-feng LIU, Lei CAO, Hua YANG, et al. Effect of Addition and Subtraction Therapy of Yiyiren Tang with External Application Therapy on Inflammatory Factors of Patients with Acute Gouty Arthritis and Damp-heat Obstruction Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(9): 75-80.
DOI：

Yi-feng LIU, Lei CAO, Hua YANG, et al. Effect of Addition and Subtraction Therapy of Yiyiren Tang with External Application Therapy on Inflammatory Factors of Patients with Acute Gouty Arthritis and Damp-heat Obstruction Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(9): 75-80. DOI： 10.13422/j.cnki.syfjx.20200132.

摘要

目的：

观察薏苡仁汤加减内服和外敷治疗急性痛风性关节炎(AGA)湿热痹阻证的临床疗效及对炎症因子的影响。

方法：

将153例AGA患者随机按数字表法分为对照组77例和观察组76例。对照组采用美洛昔康片，1片/次，1次/d，饭后服用；双氯芬酸钠凝胶，适量外涂患处，适当按摩，3次/d。观察组美洛昔康片使用同对照组，并给予薏苡仁汤加减内服、外敷。两组疗程均为治疗7 d。患者每日记录疼痛视觉模拟评分(VAS)，记录疼痛缓解时间和疼痛消失时间；进行治疗前后湿热痹阻证评分；检测治疗前后尿酸(UA)，C-反应蛋白(CRP)，红细胞沉降率(ESR)，白细胞介素-1

(IL-1

)，IL-6，IL-8，肿瘤坏死因子-

(TNF-

)，血清环氧合酶-2(COX-2)，前列腺素E

(PGE

)，血栓素B

(TXB

)和6-酮-前列腺素F

(6-keto-PGF

)水平；进行安全性评价。

结果：

观察组临床疗效优于对照组(

＝2.205，

0.05)；观察组疼痛缓解时间和疼痛消失时间均短于对照组(

0.01)；观察组在治疗后1，3，5，7 d的VAS评分均低于对照组(

0.01)；治疗后观察组关节疼痛、关节压痛、关节肿胀、活动障碍等主证评分、次证评分和湿热痹阻证总分均低于对照组(

0.01)；治疗后观察组ESR，CRP，UA，IL-1

，IL-6，IL-8，TNF-

，COX-2，PGE

和TXB

水平均低于对照组(

0.01)，6-keto-PGF

水平高于对照组(

0.01)。

结论：

在美洛昔康片治疗的基础上，采用薏苡仁汤加减内服、外敷治疗AGA湿热痹阻证患者可快速缓解和消除疼痛，减轻临床主要症状，抑制炎症反应，有着较好的临床疗效，且使用安全。

Abstract

Objective:

To observe the clinical effect of addition and subtraction therapy of Yiyiren Tang with external application therapy in the patients with acute gouty arthritis (AGA) and damp-heat obstruction syndrome

and to investigate its effect on inflammatory factors.

Method:

One hundred and fifty-three patients were randomly divided into control group (77 cases) and observation group (76 cases) by random number table. Patients in control group got meloxicam tablets after the meal

1 tablet/day

1 time/day

diclofenac sodium gel

3 times/days. On the basis of meloxicam tablets

patients in observation group additionally received addition and subtraction therapy of Yiyiren Tang by oral and topical applications. The course of treatment was 7 days in both groups. Scores of visual analogue score of pain (VAS) were graded everyday

and the relief time and disappearance time of pain were recorded. Before and after treatment

scores of damp-heat obstruction syndrome were recorded. Levels of uric acid (UA)

C-reactive protein (CRP)

erythrocyte sedimentation rate (ESR)

interleukin-1 beta (IL-1

)

interleukin-6 (IL-6)

interleukin-8 (IL-8)

tumor necrosis factor-alpha (TNF-

)

serum cyclooxygenase-2 (COX-2)

prostaglandin E

(PGE

)

thromboxane B

(TXB

) and 6-keto-prostatic factor F1alpha (6-keto-PGF

) were all detected

and the safety was evaluated.

Result:

The clinical efficacy in observation group was better than that in control group (

=2.205

0.05). The relief time and disappearance time of pain were shorter than those in control group (

0.01). At the 1

and 7

day after treatment

scores of VAS were lower than those in control group (

0.01). After treatment

the scores of main symptoms such as joint pain

tenderness

swelling and dyskinesia

scores of the secondary symptoms and the total scores of damp-heat obstruction syndrome were all lower than those in control group (

0.01). After treatment

levels of ESR

CRP

IL-1

IL-6

IL-8

TNF-

COX-2

PGE

and TXB

were all lower than those in control group (

0.01).

Conclusion:

Based on the treatment of meloxicam

addition and subtraction therapy of Yiyiren Tang by oral and topical administration methods can quickly relieve and eliminate pain

alleviate the main clinical symptoms and inhibit inflammation in patients with damp-heat obstruction syndrome

showing good clinical efficacy and safety.

关键词

Keywords

references

中华医学会风湿病学分会 . 2016中国痛风诊疗指南 [J]．中华内科杂志， 2016 ， 55 ( 11 )： 892 - 899 .

舒建龙，李凤珍，覃裕旺．痛风病理及临床中西医治疗的研究进展 [J]．中国实验方剂学杂志， 2019 ， 26 ( 18 )： 1 - 10 .

谷慧敏，孟庆良，左瑞庭，等．蚕矢汤加减治疗痛风性关节炎湿热蕴结证临床观察 [J]．中国实验方剂学杂志， 2017 ， 23 ( 24 )： 180 - 184 .

尹磊，林丽雅，李学峰．急性痛风性关节炎中西医治疗研究进展 [J]．河北医药， 2017 ， 39 ( 5 )： 751-756，759 .

高岚，张仲一，张莉，等．薏苡仁汤镇痛消炎作用的实验研究 [J]．天津中医学院学报， 2005 ， 24 ( 1 )： 17 - 19 .

卿璞．薏苡仁汤加减治疗痛风性关节炎的临床研究 [J]．中国医药指南， 2014 ， 12 ( 28 )： 271 - 272 .

国家中医药管理局．中医病证诊断疗效标准 [M]．北京：中国医药科技出版社， 2012 ： 63 - 64 .

于一云，薛愉，朱小霞，等．急性痛风性关节炎的药物治疗及选择 [J]．上海医药， 2015 ， 36 ( 11 )： 14 - 18 .

李君霞，王茂杰，黄闰月，等．痛风中医证型的研究进展 [J]．中华中医药学刊， 2018 ， 36 ( 12 )： 2956 - 2958 .

于娟，王晓梅．薏苡仁和茯苓提取物对黄嘌呤氧化酶的抑制作用 [J]．中国药物与临床， 2014 ， 14 ( 1 )： 30 - 32 .

金晓敏，张晓熙，郭璐，等．基于NLRP3炎性体轴探讨土茯苓总黄酮对痛风性关节炎的作用和机制 [J]．中国实验方剂学杂志， 2018 ， 24 ( 4 )： 90 - 95 .

于舒雁，魏荣锐，苗明三．不同品种威灵仙水煎液外用对大鼠痔疮、佐剂性关节炎模型的影响 [J]．中国现代应用药学， 2014 ， 31 ( 4 )： 391 - 397 .

廉莲，贾天柱．黄柏及其炮制品的抗痛风作用研究 [J]．安徽农业科学， 2011 ， 39 ( 15 )： 8911 - 8912 .

张柯媛，熊灏，曹斌，等．海风藤提取物灌胃对高尿酸血症小鼠血清尿酸水平影响及对痛风大鼠足跖肿胀的防治作用 [J]．山东医药， 2017 ， 57 ( 27 )： 37 - 39 .

董鹏，宋慧．痛风发病机制研究进展 [J]．基础医学与临床， 2015 ， 35 ( 12 )： 1695 - 1699 .

梁晖，张意侗，解纪惠，等．急性痛风性关节炎患者血清IL-1 β ，IL-6, IL-8与疼痛的相关性 [J]．河北医学， 2019 ， 25 ( 1 )： 22 - 25 .

C DHANASEKAR , M RASOOL . Morin, a dietary bioflavonol suppresses monosodium urate crystal-induced inflammation in an animal model of acute gouty arthritis with reference to NLRP3 inflammasome, hypo-xanthine phospho-ribosyl transferase, and inflammatory mediators [J]. Eur J Pharmacol , 2016 , 786 ： 116 - 127 .

Q B ZHANG , Y F QING , C C YIN , et al . Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome [J]. Arthritis Res Ther , 2018 , 20 ( 1 )： 45 - 55 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Efficacy of Early Application of Da Xianxiongtang in Mitigating Progression of Acute Pancreatitis

Efficacy of Shexiang Tongxin Dropping Pills in Treatment of Coronary Slow Flow and Its Effect on Inflammatory Factors

Effect of Zishen Tongguan Formula on "Gut-prostate" Axis of Rats with Chronic Non-bacterial Prostatitis Based on 16S rDNA Sequencing

Effect of Rhei Radix et Rhizoma Before and After Steaming with Wine on Intestinal Flora and Immune Environment in Constipation Model Mice

Exploring Mechanism of Different Processed Products of Baiyaojian and Its Formula in Treating Ulcerative Colitis Based on Serum Metabolomics and Flow Cytometry

Related Author

REN Dongsheng

TAN Judan

LIAO Haitang

LIU Qinghai

WENG Xiangwen

GUO Wenhui

WANG Yiyan

ZHOU Yuling

Related Institution

Chengdu University of Traditional Chinese Medicine（TCM）

Chongqing TCM Hospital

Hospital of Chengdu University of TCM

Dongzhimen Hospital， Beijing University of Chinese Medicine

Jiangsu Engineering Research Centre for Innovative Chinese Medicine Preparations， Jiangsu Integration Innovation Centre for Specialty Chinese Medicine Preparations，Affiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Province Hospital of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰